ReShape Lifesciences - RSLS Company profit before taxes, interest and amortization
ReShape Lifesciences (RSLS) is expanding its business in the supply of bariatric consumables to create a recurring revenue stream. Changes in EBITDA_Co visualize this trajectory, with the current figure standing at . Lap-Band safety systems ensure stable pricing within the weight loss niche. The company is currently transforming its sales into comprehensive programs to mitigate pressure from new pharmaceutical drugs.
Summary analytical data breakdowns for ReShape Lifesciences Inc. (RSLS)
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio ReShape Lifesciences|RSLS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ReShape Lifesciences, Inc.|RSLS - Company Aggregate Debts|Debts to Book Value ReShape Lifesciences|RSLS - Company Long-Term Debts|Company Short-Term Indebtedness ReShape Lifesciences|Interim Coverage Ratio reshapelifesciences.com
- company profitability and valuation multiples indicators:
RSLS - Net Profit|Future Profit ReShape Lifesciences|RSLS - P/E Multiple|Forward P/E Multiple ReShape Lifesciences, Inc.|RSLS - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ReShape Lifesciences|RSLS - Operating profit before deduction of amortization|Earnings per share for the trailing year ReShape Lifesciences|RSLS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months reshapelifesciences.com|RSLS - Earnings per share growth in current year|Net earnings per one share growth forecast for next year ReShape Lifesciences
Summary company analytics:ReShape Lifesciences
Amid competition from GLP-1 drugs, ReShape Lifesciences is optimizing its surgical business, as reflected in its EBITDA dynamics. The current value of represents the operating cash flow before depreciation, excluding non-cash charges to assess the company's actual ability to generate cash, which is critical for confirming financial stability during the period of asset restructuring.
Who ReShape Lifesciences competes with
Operating profit EBITDA Dexcom CGM DXCM|PEN: Operating profit before deduction of amortization|novanta.com - Company profit before taxes, interest and amortization|HAE: Operating profit EBITDA|INSP - Operating income before deduction of amortization|PRCT (PROCEPT BioRobotics Inc) - Operating profit EBITDA|Operating profit before deduction of amortization CONMED Inc. (CNMD)|Operating profit before deduction of amortization PLSE (Pulse Biosciences, Inc.)|INMD (inmodemd.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Picard Medical PMI|SRDX - Operating profit before deduction of amortization|Eversense - Operating profit EBITDA|Profit before interest, taxes and amortization NeuroPace Medical|TCMD: Operating profit EBITDA|Operating profit before amortization SNWV|OM (Outset Medical) - Operating profit EBITDA|Electromed Inc (ELMD) - Operating income before deduction of amortization|Operating profit EBITDA LNSR|Operating profit before deduction of amortization AVITA Medical Inc RCEL|Operating profit EBITDA PROF (Profound Medical)|Operating profit EBITDA Baird Medical Investment Holdings BDMD|EDAP - Profit before payment of interest, taxes and amortization|APYX: Profit before payment of interest, taxes and amortization|ICCM (icecure-medical.com) - Operating profit before deduction of amortization|Pulmonx - Income before deduction of interest, taxes and amortization|TELA (TELA Bio Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization CytoSorbents Corp. CTSO|Profit before payment of interest, taxes and amortization Sensus Healthcare (SRTS)|Zynex Medical (ZYXI) - Operating profit before depreciation charges|electroCore - Operating profit before deduction of amortization|Operating profit EBITDA Vicarious Surgical Inc RBOT|Inspira Technologies Oxy B.H.N. Ltd - Operating profit EBITDA|Operating income before deduction of amortization seastarmedical.com ICU|iridex.com (IRIX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization INBS (Intelligent Bio Solutions Inc.)|Profit before payment of interest, taxes and amortization Beyond Air Inc|Operating profit before deduction of amortization Profusa, Inc (PFSA)|Operating profit EBITDA SSKN|GCTK - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization NanoVibronix NAOV|VERO: Operating profit before amortization|NUWE: Operating profit before deduction of amortization|Aethlon Medical Corp - Company profit before taxes, interest and amortization|asensus.com (ASXC) - Profit before payment of interest, taxes and amortization|avinger.com - Income before deduction of interest, taxes and amortization|BSGM (BioSig) - Operating profit EBITDA|Profit before interest, taxes and amortization Cutera Inc. CUTR|Profit before payment of interest, taxes and amortization Know Labs Corp (KNW)|Operating income before deduction of amortization Inari Medical Corp|Operating profit EBITDA NVRO (Nevro Corp.)|Income before deduction of interest, taxes and amortization SILK
